NCT04558450 Covid-19 Effects on Arterial Stiffness and Vascular Aging (CARTESIAN)
| NCT ID | NCT04558450 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Condition | Covid19 |
| Study Type | INTERVENTIONAL |
| Enrollment | 360 participants |
| Start Date | 2020-09-21 |
| Primary Completion | 2023-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 360 participants in total. It began in 2020-09-21 with a primary completion date of 2023-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of the study is to evaluate the presence of early vascular aging 6 months and 12 months after COVID-19 infection.
Eligibility Criteria
Inclusion Criteria: * age \>18 years, both sexes; * written informed consent; * affiliation to a social security regime; * a recent diagnosis of COVID19 (6±3 months) proven by PCR or serology (for group 1,2,3) * hospitalization in intensive care unit for COVID19 (for group 1) * hospitalization in a medicine unit for COVID19 (for group 2) * no hospitalization for COVID19 or hospitalization less than 24h (for group 3) * a negative test for SARS-nCOV2 infection (PCR or serology)(for group 4) Exclusion Criteria: * Age \<18 years * Inability to express consent of the study * Diseases carrying out a life -expectancy \<1 year according to clinical judgment * Pregnancy and breastfeeding * Foreseen inability to attend scheduled visits
Contact & Investigator
Pierre BOUTOUYRIE, MD PHD
PRINCIPAL INVESTIGATOR
Assistance Publique - Hôpitaux de Paris
Frequently Asked Questions
Who can join the NCT04558450 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Covid19. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04558450 currently recruiting?
Yes, NCT04558450 is actively recruiting participants. Contact the research team at rosa-maria.bruno@inserm.fr for enrollment information.
Where is the NCT04558450 trial being conducted?
This trial is being conducted at Nancy, France, Paris, France, Rouen, France.
Who is sponsoring the NCT04558450 clinical trial?
NCT04558450 is sponsored by Assistance Publique - Hôpitaux de Paris. The principal investigator is Pierre BOUTOUYRIE, MD PHD at Assistance Publique - Hôpitaux de Paris. The trial plans to enroll 360 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.